Literature DB >> 2698751

Long-term maintenance of improvements achieved with (abortive) pharmacological and nonpharmacological treatments for migraine: preliminary findings.

K A Holroyd1, J F Holm, D B Penzien, G E Cordingley, K G Hursey, N J Martin, A Theofanous.   

Abstract

This report presents the first prospective comparison of the long-term maintenance of reductions in recurrent migraine headaches achieved with (abortive) pharmacological and nonpharmacological (combined relaxation training and thermal biofeedback training) treatments. Nineteen of 21 (90%) successfully treated patients (50% or greater reduction in headache activity) were contacted for follow-up evaluation 3 years later. Migraine sufferers who had been treated with ergotamine were less likely to still be relying on the treatment they had received and more likely to have additional medical treatment for their headaches and to be using prophylactic or narcotic medication than were migraine sufferers who had been treated with relaxation/biofeedback training. However, daily headache recordings revealed that patients in both treatment groups continued to show lower headache activity at 3-year follow-up than prior to treatment. Although preliminary, these findings raise the possibility that improvements achieved with nonpharmacological treatment are more likely to be maintained without additional treatment than are similar improvements achieved with abortive pharmacological treatment.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2698751     DOI: 10.1007/BF00999121

Source DB:  PubMed          Journal:  Biofeedback Self Regul        ISSN: 0363-3586


  6 in total

Review 1.  Ergotamine dependency--a review.

Authors:  J R Saper
Journal:  Headache       Date:  1987-09       Impact factor: 5.887

2.  Recurrent vascular headache: home-based behavioral treatment versus abortive pharmacological treatment.

Authors:  K A Holroyd; J E Holm; K G Hursey; D B Penzien; G E Cordingley; A G Theofanous; S C Richardson; D L Tobin
Journal:  J Consult Clin Psychol       Date:  1988-04

3.  Transformation of episodic migraine into daily headache: analysis of factors.

Authors:  N T Mathew; E Stubits; M P Nigam
Journal:  Headache       Date:  1982-03       Impact factor: 5.887

4.  Long-term study of propranolol in the treatment of migraine.

Authors:  S Diamond; L Kudrow; J Stevens; D B Shapiro
Journal:  Headache       Date:  1982-11       Impact factor: 5.887

5.  Ergotamine abuse: results of ergotamine discontinuation, with special reference to the plasma concentrations.

Authors:  V Ala-Hurula; V Myllylä; E Hokkanen
Journal:  Cephalalgia       Date:  1982-12       Impact factor: 6.292

6.  Enhancing the effectiveness of abortive therapy: a controlled evaluation of self-management training.

Authors:  K A Holroyd; G E Cordingley; J D Pingel; A Jerome; A G Theofanous; D K Jackson; L Leard
Journal:  Headache       Date:  1989-03       Impact factor: 5.887

  6 in total
  2 in total

1.  Development of a measure of self-efficacy for acute headache medication adherence.

Authors:  Elizabeth K Seng; Robert A Nicholson; Kenneth A Holroyd
Journal:  J Behav Med       Date:  2015-09-24

Review 2.  Biofeedback and behavioral treatments: filling some gaps.

Authors:  Frank Andrasik; Licia Grazzi
Journal:  Neurol Sci       Date:  2014-05       Impact factor: 3.307

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.